home / stock / atnx / atnx news


ATNX News and Press, Athenex Inc. From 07/06/21

Stock Information

Company Name: Athenex Inc.
Stock Symbol: ATNX
Market: NASDAQ

Menu

ATNX ATNX Quote ATNX Short ATNX News ATNX Articles ATNX Message Board
Get ATNX Alerts

News, Short Squeeze, Breakout and More Instantly...

ATNX - Athenex Provides Update from FDA Type A Meeting Regarding Oral Paclitaxel Plus Encequidar for the Treatment of Metastatic Breast Cancer

BUFFALO, N.Y., July 06, 2021 (GLOBE NEWSWIRE) -- Athenex, Inc., (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for the treatment of cancer and related conditions, today announced that the Company held a Ty...

ATNX - Athenex Presents Data on Oral Docetaxel and Oral Paclitaxel at ASCO2021 Virtual Scientific Program

Data from oral docetaxel phase I pharmacokinetic study shows oral administration can achieve exposure comparable to IV docetaxel Post-hoc subgroup efficacy analysis based on updated tumor subtypes in the oral paclitaxel phase III study demonstrated an improved response rate wi...

ATNX - ASCO 2021: A Plethora Of Cancer Therapeutic Investment Ideas

ASCO is a very important cancer clinical research meeting. We identified 70 smid-cap cancer companies presenting updated clinical data at ASCO21. 13 companies' value increased by over 10% with ASCO21 info release thus far. PDSB is an early ASCO21 mover, with its HPV vaccine ca...

ATNX - Athenex says Almirall's klisyri treatment gets positive CHMP opinion

Athenex ([[ATNX]] +0.4%) announces that its partner, Almirall, has received a positive opinion from the Committee for Medicinal Products for Human Use ((CHMP)) of EMA for the regulatory approval of Klisyri (tirbanibulin), indicated for the topical treatment of actinic keratosis ((AK)) of...

ATNX - Athenex Announces Klisyri® (tirbanibulin) Receives Positive CHMP Opinion from the European Medicines Agency (EMA) for the Treatment of Actinic Keratosis of the Face or Scalp

BUFFALO, N.Y., May 21, 2021 (GLOBE NEWSWIRE) -- Athenex, Inc., (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for the treatment of cancer and related conditions, announced today that its partner, Almirall ...

ATNX - Increased R&D Activities Have Fueled Growth and Promise for Pancreatic Cancer Treatment

Palm Beach, FL –May 20, 2021 – Sadly, for patients, the pancreatic cancer market has been steadily rising over the past several years and will most likely continue to grow over the next couple of years. Revenues will increase but so will money flow into R&D efforts to trea...

ATNX - Athenex, Texas Children's Cancer Center, and the Center for Cell and Gene Therapy at Baylor College of Medicine Present New Clinical Data on GD2 CAR-NKT Cells in Neuroblastoma at ASGCT Annual Meeting

Data presented by investigators from the Texas Children’s Cancer Center One PR, one CR and four SDs out of 11 patients enrolled GD2 CAR NKT cells were well tolerated with no dose limiting toxicities CAR-NKT AUC normalized to disease burden (AUC/Curie score...

ATNX - 5 Robinhood Penny Stocks That You Should Know About in May

These 5 Penny Stocks Are Showing Solid Momentum Right Now A penny stock is defined as a security that trades under $5 per share. Because penny stocks are low priced, using them to make large intraday gains has become very popular. At the same time, these stocks are highly volatile, ...

ATNX - Athenex, Inc. (ATNX) CEO Johnson Lau on Q1 2021 Results - Earnings Call Transcript

Athenex, Inc. (ATNX) Q1 2021 Earnings Conference Call May 06, 2021 8:00 AM ET Company Participants Steven Rubis – Senior Director, Investor Relations Johnson Lau – Chief Executive Officer Jeff Yordon – Chief Operating Officer Rudolf Kwan – Chief Medical Officer Ran...

ATNX - Athenex, Inc. (ATNX) Q1 2021 Earnings Call Transcript

Image source: The Motley Fool. Athenex, Inc. (NASDAQ: ATNX) Q1 2021 Earnings Call May 7, 2021 , 8:00 p.m. ET Operator Continue reading For further details see: Athenex, Inc. (ATNX) Q1 2021 Earnings Call Transcript

Previous 10 Next 10